Apis Capital Advisors’s MiMedx Group MDXG Stock Holding History

Apis Capital Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40,000	Closed	-$363K	–	48
2020 Q4	$363K	Buy	+40,000	New	+$288K	0.35%	38

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Apis Capital Advisors's MDXG Position: Q1 2021 in Review

Apis Capital Advisors sold out of MiMedx Group (MDXG) in Q1 2021, closing a stake of 40,000 shares — an estimated $363K sold.

Apis Capital Advisors first reported a position in MDXG in Q4 2020 and held it in 1 quarter. The position peaked at $363K in Q4 2020. 112 funds tracked by Wall St. Rank hold MDXG as of Q1 2021.

Apis Capital Advisors reported no remaining MiMedx Group position as of Q1 2021 after selling out during the quarter.
Apis Capital Advisors sold 40,000 MiMedx Group shares in Q1 2021, an estimated $363K.
Apis Capital Advisors first reported a position in MiMedx Group in Q4 2020 and held it in 1 quarter.
Apis Capital Advisors's MiMedx Group position peaked at $363K in Q4 2020.
112 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2021.

Based on Apis Capital Advisors's 13F filing for Q1 2021, filed 14 May 2021.